Organised by DG Health and Food Safety (DG SANTE), European Commission
EU patients should be able to rely on accessible healthcare systems and access to innovative, safe and affordable treatments. Despite its limited competence, the EU can have an added value.
Vytenis Andriukaitis, EU Commissioner for Health and Food Safety
How can EU initiatives improve access to high-quality care for citizens? Can access be facilitated by better workforce planning and increased patient mobility?
Andrey Kovatchev, Member of European Parliament (EPP, Bulgaria)
Luís Mendão, Vice-chair, European AIDS Treatment Group
Walter Sermeus, Professor in Healthcare Management, Centre for Health Services & Nursing Research, Catholic University Leuven, Belgium
Dorjan Marušic, Former Minister of Health and Member of the Expert Panel, Slovenia
Which patient needs should frame the future medicines market landscape and what is the role of the pharmaceutical industry? What are the benefits of a long-term EU-level cooperation and how can innovative initiatives from Member States’ cooperation be successfully applied?
Maria Iglesia, Head of Unit for Healthcare Systems, DG Health and Food Safety (DG SANTE), European Commission
Stanimir Hasurdjiev, Board Member, European Patients' Forum
Marcel van Raaij, Director, Ministry of Health, Welfare and Sports, The Netherlands
Hans Kluge, Director, Health Systems and Public Health, WHO Regional Office for Europe
Richard Bergström, Director General, European Federation of Pharmaceutical Industries and Associations (EFPIA)
Peter O'Donnell, Associate Editor, POLITICO